Komipharm International Co., Ltd.

₩8,550As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:041960Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (11.91%)
Div yield —
ROE (4.72%)
Biotechnology
Beta (5Y) 0.26
PE TTM —
TSR TTM 41.56%
Mkt cap ₩614.6B
ROIC 1.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,476
10.83%
(59.20%)
Hold 9|11|6|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
190.89
190.16
207.65
222.93
26.32%
17.19%
18.73%
21.26%
Revenue₩B
63.93
62.36
65.91
65.52
0.09%
0.63%
6.86%
5.86%
Peers (US$453.1M)
Cap (US$)
PE
497.2M
623.0x
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.836
0.077
0.061
EBIT/Intx
1.361
0.257
0.256
Own earn%
(28.32)
(184.60)
(147.54)
Sh yield%
36.23
13.22
9.66
Owners
Insiders/Inst%
3.57
62.17
Short interest%
3.01
SBC / revenue%
4.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–11
$1 testx
2.7
Incr. ROIC%
19